Ceva attracts strong investor support for 4th LMBO and returns to double-digit growth in first 6 months of 2014
Consolidated first semester sales of Ceva Group reached €366.5m at the end of June representing growth of 18.3% versus last year.
Ceva publishes latest annual report (2013) with first digital version
Global veterinary health company, Ceva Sante Animale who completed their 4th LBO deal on the 30th June published their annual report on the same day.
Ceva Santé Animale reorganizes its capital structure to bolster its international ambitions
The management of Ceva Santé Animale announces a reshaping of its capital structure through a new round of financing which strengthens its position as majority shareholder and welcomes new investors.
Ceva proposes new respiratory health programs to allow swine experts to “breathe easy”
Symposium held prior to ESPHM presents benefits of more targeted vaccination
Ceva: Co-operation to prevent zoonosis
A conference was held to facilitate the control of diseases transmissible from animals to humans.
Ceva concludes long term agreement with Jinyu Baoling to produce brucellosis vaccines in China
Ceva sealed its synergistic collaboration with partners Jinyu Baoling following the signature of a technical and trademark license to produce international standard brucellosis vaccines in China.
CEVA in APVS 2013 - The Asian Pig Veterinary Society Congress
The 6th Asian Pig Veterinary Society Congress (APVS 2013) will be held during 23rd - 25th Sept 2013 at White Palace Convention Center - 194 Hoang Van Thu st., Phu Nhuan Dist., Ho Chi Minh City, Vietnam.
Ceva’s growth continues despite difficult market conditions
Consolidated sales of the Ceva Group reached €310m in the first 6 months of 2013, up by 2%, 4.2% on the previous year at a constant perimeter and exchange rates.
Ceva Santé Animale signs a joint-venture with Sichuan Hengtong Animal Pharmacy Co., a new partner in China
Ceva Santé Animale, a global veterinary group based in Aquitaine, France (Libourne) and Sichuan Hengtong Animal Pharmacy Co., a veterinary company in Sichuan (Neijiang, China), have signed an international partnership agreement
Ceva Santé Animale gathers 150 experts from 18 countries for swine reproduction symposium
The symposium which brought together professionals from Europe’s main swine producing areas, featured presentations ranging from the genetic potential of animals and tools, to new knowledge on the use of hormones in swine reproduction, with the clear objective of improving farm production indices, lowering production costs and increasing profits of pork producers.
Ceva takes commercial license for ProBioGen's AGE1.CR® Cell Line for viral vaccine production
Ceva and ProBioGen announced the signature of a multi-product license agreement for the use of ProBioGen’s AGE1.CR® avian cell line in the industrial production of viral animal vaccines.
Ceva continues rapid growth in 2011
Twin pillar strategy of combining internal and external growth opportunities drives further global expansion.
Focus on the latest scientific research, applied to field conditions for the improved control of AP
The scientific program focused on the epidemiology, pathology, and vaccinology surrounding A.p. Over 100 guests attended from Asia, South America, Eastern Europe and the EU to share knowledge about the disease.
Contact:
Contact us using the following form.